SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001457612-20-000099
Filing Date
2020-06-19
Accepted
2020-06-19 16:08:25
Documents
1
Period of Report
2020-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159259728752944.html 4  
1 FORM 4 wf-form4_159259728752944.xml 4 3819
  Complete submission text file 0001457612-20-000099.txt   5283
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O EDITAS MEDICINE 11 HURLEY STREET CAMBRIDGE MA 02141
Business Address
Bosley Katrine (Reporting) CIK: 0001592469 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36289 | Film No.: 20975710